| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |